NASDAQ:CERT

Certara News Headlines

$27.53
+0.63 (+2.34 %)
(As of 06/17/2021 04:30 PM ET)
Add
Compare
Today's Range
$27.02
$28.20
50-Day Range
$24.79
$33.31
52-Week Range
$24.36
$41.79
Volume197,213 shs
Average Volume602,980 shs
Market Capitalization$4.21 billion
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Certara (NASDAQ CERT) News Headlines Today

SourceHeadline
Critical Analysis: Certara (CERT) and Its CompetitorsCritical Analysis: Certara (CERT) and Its Competitors
americanbankingnews.com - June 17 at 9:50 AM
Insider Selling: Certara, Inc. (NASDAQ:CERT) Insider Sells 19,354 Shares of StockInsider Selling: Certara, Inc. (NASDAQ:CERT) Insider Sells 19,354 Shares of Stock
americanbankingnews.com - June 15 at 2:46 PM
Insider Selling: Certara, Inc. (NASDAQ:CERT) Insider Sells 108,924 Shares of StockInsider Selling: Certara, Inc. (NASDAQ:CERT) Insider Sells 108,924 Shares of Stock
americanbankingnews.com - June 15 at 2:46 PM
Certara (NASDAQ:CERT) Shares Gap Down to $27.16Certara (NASDAQ:CERT) Shares Gap Down to $27.16
americanbankingnews.com - June 11 at 11:24 AM
Certara (NASDAQ:CERT)  Shares Down 4.5% Certara (NASDAQ:CERT) Shares Down 4.5%
americanbankingnews.com - June 7 at 1:38 PM
Head-To-Head Comparison: Certara (NASDAQ:CERT) vs. Zuora (NYSE:ZUO)Head-To-Head Comparison: Certara (NASDAQ:CERT) vs. Zuora (NYSE:ZUO)
americanbankingnews.com - June 7 at 5:10 AM
Certara (CERT) and Its Competitors Head-To-Head ReviewCertara (CERT) and Its Competitors Head-To-Head Review
americanbankingnews.com - June 1 at 11:16 PM
Financial Comparison: Certara (CERT) & Its RivalsFinancial Comparison: Certara (CERT) & Its Rivals
americanbankingnews.com - May 31 at 11:12 PM
Certara to Participate in the William Blair Growth Stock Conference and Jefferies Virtual Healthcare ConferenceCertara to Participate in the William Blair Growth Stock Conference and Jefferies Virtual Healthcare Conference
finance.yahoo.com - May 20 at 12:08 PM
Certara Releases New Versions of Its Preeminent Quantitative Systems Pharmacology (QSP) Simulators for Expediting Development of Biologics and Immuno-oncology TherapiesCertara Releases New Versions of Its Preeminent Quantitative Systems Pharmacology (QSP) Simulators for Expediting Development of Biologics and Immuno-oncology Therapies
finance.yahoo.com - May 13 at 8:30 AM
Have Insiders Been Buying Certara, Inc. (NASDAQ:CERT) Shares?Have Insiders Been Buying Certara, Inc. (NASDAQ:CERT) Shares?
finance.yahoo.com - May 10 at 7:44 AM
Certara, Inc. 2021 Q1 - Results - Earnings Call PresentationCertara, Inc. 2021 Q1 - Results - Earnings Call Presentation
seekingalpha.com - May 7 at 11:27 AM
BRIEF-Certara Q1 Revenue Rose 16 Percent To $66.7 MillionBRIEF-Certara Q1 Revenue Rose 16 Percent To $66.7 Million
msn.com - May 6 at 11:10 PM
Certara Reports First Quarter 2021 Financial Results and Updates Full Year 2021 GuidanceCertara Reports First Quarter 2021 Financial Results and Updates Full Year 2021 Guidance
finance.yahoo.com - May 6 at 6:10 PM
Certara Launches Secondary Intelligence™ Software to Predict Risk of Unwanted Side Effects of Drug Candidates EarlierCertara Launches Secondary Intelligence™ Software to Predict Risk of Unwanted Side Effects of Drug Candidates Earlier
finance.yahoo.com - May 4 at 11:15 PM
Certara to Present at the BofA Securities 2021 Virtual Health Care ConferenceCertara to Present at the BofA Securities 2021 Virtual Health Care Conference
finance.yahoo.com - April 30 at 9:54 AM
Certara to Report Preliminary First Quarter 2021 Financial Results on May 6, 2021Certara to Report Preliminary First Quarter 2021 Financial Results on May 6, 2021
finance.yahoo.com - April 22 at 5:55 PM
Certara, Inc. (NASDAQ:CERT) On The Verge Of Breaking EvenCertara, Inc. (NASDAQ:CERT) On The Verge Of Breaking Even
nasdaq.com - April 11 at 2:38 PM
Insiders Now Seeing Red With CERT At New 52-Week LowInsiders Now Seeing Red With CERT At New 52-Week Low
nasdaq.com - March 30 at 6:11 PM
Certara Announces Closing of Public Offering of Common StockCertara Announces Closing of Public Offering of Common Stock
finance.yahoo.com - March 29 at 5:07 PM
Certara Announces Pricing of Public Offering of Common StockCertara Announces Pricing of Public Offering of Common Stock
finance.yahoo.com - March 25 at 2:03 AM
Certara Announces Proposed Public Offering of Common StockCertara Announces Proposed Public Offering of Common Stock
finance.yahoo.com - March 22 at 6:29 PM
Certara Adopts TrialAssure ANONYMIZE Solution to Speed Life Science Industry Need to Meet Regulatory Requirements for Data SharingCertara Adopts TrialAssure ANONYMIZE Solution to Speed Life Science Industry Need to Meet Regulatory Requirements for Data Sharing
finance.yahoo.com - March 16 at 12:26 PM
Stocks in play: NeonMind Biosciences Inc.Stocks in play: NeonMind Biosciences Inc.
ca.finance.yahoo.com - March 11 at 5:31 PM
Certara Set to Join Russell 1000® IndexCertara Set to Join Russell 1000® Index
finance.yahoo.com - March 11 at 12:30 PM
NeonMind Engages Certara to Advance its Synthetic Psilocybin Drug Candidates for ObesityNeonMind Engages Certara to Advance its Synthetic Psilocybin Drug Candidates for Obesity
finance.yahoo.com - March 11 at 7:30 AM
Could The Certara, Inc. (NASDAQ:CERT) Ownership Structure Tell Us Something Useful?Could The Certara, Inc. (NASDAQ:CERT) Ownership Structure Tell Us Something Useful?
finance.yahoo.com - March 11 at 7:30 AM
Morgan Stanley Maintains Equal-Weight on Certara, Lowers Price Target to $33Morgan Stanley Maintains Equal-Weight on Certara, Lowers Price Target to $33
benzinga.com - March 8 at 6:35 PM
RSI Alert: Certara (CERT) Now OversoldRSI Alert: Certara (CERT) Now Oversold
nasdaq.com - March 5 at 1:51 PM
Certara, Inc. 2020 Q4 - Results - Earnings Call PresentationCertara, Inc. 2020 Q4 - Results - Earnings Call Presentation
seekingalpha.com - March 5 at 2:41 AM
Asia Pacific Medical Writing Market Report 2020-2027: High Growth in Clinical Research and Trials Presents OpportunitiesAsia Pacific Medical Writing Market Report 2020-2027: High Growth in Clinical Research and Trials Presents Opportunities
finance.yahoo.com - March 4 at 8:10 AM
Certara Inc Registered Shs hosts conference call for investorsCertara Inc Registered Shs hosts conference call for investors
markets.businessinsider.com - February 27 at 5:44 PM
Certara to Present at the Barclays Global Healthcare ConferenceCertara to Present at the Barclays Global Healthcare Conference
finance.yahoo.com - February 26 at 3:30 PM
The Year 2020 Marks the 7th Consecutive Year Certara Customers Received 90 Percent of US FDA Novel Drug and Biologic ApprovalsThe Year 2020 Marks the 7th Consecutive Year Certara Customers Received 90 Percent of US FDA Novel Drug and Biologic Approvals
finance.yahoo.com - February 25 at 6:34 PM
Certara to Report Fourth Quarter and Full Year 2020 Preliminary Financial Results on March 4, 2021Certara to Report Fourth Quarter and Full Year 2020 Preliminary Financial Results on March 4, 2021
finance.yahoo.com - February 17 at 9:35 AM
CERT Crosses Above Average Analyst TargetCERT Crosses Above Average Analyst Target
nasdaq.com - February 9 at 12:32 PM
Certara Holdco, Inc. -- Moodys announces completion of a periodic review of ratings of Certara Holdco, Inc.Certara Holdco, Inc. -- Moody's announces completion of a periodic review of ratings of Certara Holdco, Inc.
markets.businessinsider.com - February 4 at 6:04 PM
Certara Releases Simcyp™ PBPK Simulator Version 20, Including Newly Expanded Biologics SoftwareCertara Releases Simcyp™ PBPK Simulator Version 20, Including Newly Expanded Biologics Software
finance.yahoo.com - January 27 at 12:25 PM
Certara Inc Registered Shs Equal WeightCertara Inc Registered Shs Equal Weight
markets.businessinsider.com - January 7 at 9:57 PM
Certara Inc Registered Shs OutperformCertara Inc Registered Shs Outperform
markets.businessinsider.com - January 7 at 1:08 AM
Certara, Inc. (CERT)Certara, Inc. (CERT)
uk.finance.yahoo.com - January 1 at 12:11 AM
Certara Holdco, Inc. -- Moodys upgrades Certaras CFR to B2 following IPO and planned debt paydown; outlook positiveCertara Holdco, Inc. -- Moody's upgrades Certara's CFR to B2 following IPO and planned debt paydown; outlook positive
markets.businessinsider.com - December 18 at 1:42 PM
EQT VII portfolio company Certara closes Initial Public OfferingEQT VII portfolio company Certara closes Initial Public Offering
markets.businessinsider.com - December 17 at 9:25 AM
Certara Announces Closing of Its Upsized Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional SharesCertara Announces Closing of Its Upsized Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
finance.yahoo.com - December 16 at 10:21 PM
PE Daily: Certara Shares Soar | Alaska Permanent’s Private-Equity Rebound | NGP Makes a Play for Mineral RightsPE Daily: Certara Shares Soar | Alaska Permanent’s Private-Equity Rebound | NGP Makes a Play for Mineral Rights
wsj.com - December 14 at 1:33 PM
Certara Announces Pricing of Its Upsized Initial Public OfferingCertara Announces Pricing of Its Upsized Initial Public Offering
finance.yahoo.com - December 14 at 8:33 AM
AbCellera Rockets 195%, 4D Molecular Up 76% as Flurry of Health-Care IPOs Begin TradingAbCellera Rockets 195%, 4D Molecular Up 76% as Flurry of Health-Care IPOs Begin Trading
finance.yahoo.com - December 14 at 8:33 AM
Certara IPO Soars 66%. Employees Will Get Shares.Certara IPO Soars 66%. Employees Will Get Shares.
finance.yahoo.com - December 14 at 8:33 AM
This page was last updated on 6/17/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.